Home | Welcome to Contract Pharma   
Last Updated Monday, May 25 2015


Trials & Filings in Brief: Jan. 7, 2014

By Gil Roth

Published January 7, 2014
Related Searches: Phase II Phase III contractpharma.com www.contractpharma.com
Phase II
Erytech to begin pancreatic cancer study . . . read more

Galena enrolls first ovarian cancer patient . . . read more

Neurocrine Biosciences posts positive results in tardive dyskinesia . . . read more

TeaRx begins anticoagulant trial . . . read more

Phase III
Positive results for Shield's IDA treatment in IBD . . . read more

Celgene's Abraxane approved in EU for pancreatic cancer . . . read more

Alitair gets orphan status for bronchiectasis treatment . . . read more

Orexigen gets Contrave PDUFA date . . . read more

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On